Maíra Cristina Marcolino

Ms. Maíra Cristina Marcolino

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2025 in ACS Omega
Verified
Journal Article
Open access
Maíra Cristina MarcolinoMaíra Cristina Marcolino
Maíra Cristina Marcolino
MGMilena L. Guimarães
Milena L. Guimarães
MFMarina de L. Fontes
Marina de L. Fontes
FRFlávia A. Resende
Flávia A. Resende
Hernane Silva BarudHernane Silva Barud
Hernane Silva Barud
Helinando De OliveiraHelinando De Oliveira
Helinando De Oliveira
Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-related infections caused by biofilm formation. This research investigated the efficacy of polypyrrole (PPy), silver nanoparticles (AgNPs), and their combination (PPy/AgNPs) as water-soluble additives applied in cleaning procedures for preventing the formation of Escherichia coli and Staphylococcus aureus (single and dual-species biofilms) on silicone. Ultraviolet–visible absorption assays, scanning electron microscopy (SEM) images, FTIR analysis, and dynamic light scattering experiments were conducted to evaluate the structure and physicochemical response of the antibiofilm compounds, with the biofilm prevention concentrations assessed by plate counting, flow cytometry, and SEM images. The composites proved to be dose-dependent agents preventing single- and dual-species biofilms from forming under simulated CAUTI conditions. Furthermore, cytotoxicity assays indicated that the materials are non-cytotoxic, supporting their suitability for biomedical applications. These findings pave the way for developing more effective, biocompatible catheter cleaning procedures, ultimately improving patient outcomes and addressing biofilms-related infections in clinical settings.

1 January 2021 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
Maíra Cristina MarcolinoMaíra Cristina Marcolino
Maíra Cristina Marcolino
JJJoão C.A. DE Sousa Júnior
João C.A. DE Sousa Júnior
CDCarlos Henrique A. Dias
Carlos Henrique A. Dias
CNCarine R. Naue
Carine R. Naue
FMFlávia B. DE Souza Melo
Flávia B. DE Souza Melo
MCMaryluce A. DA Silva Campos
Maryluce A. DA Silva Campos
Guava (Psidium guajava L.), is adapted to tropical and subtropical climates, and, in addition to its nutritional value, has great medicinal potential. One of the medicinal effects is antibacterial, and this can be identified from the phytochemicals present in its various parts, especially the leaf, which contains flavonoids, phenols, and tannins, as well as phytocomposites with antibacterial action. Therefore, the interaction of this plant with arbuscular mycorrhizal fungi and Meloidogyne enterolobii is a biotechnological resource that can increase the production of secondary metabolites so that the guava ethanolic extract is effective against multidrug-resistant bacterial strains. Therefore, the objective of this study was to test the inhibitory action of mycorrhizal guava leaf extract and Meloidogyne enterolobii on strains of Klebsiella pneumoniae carbapenemase. Guava seedlings from cuttings were inoculated with Acaulospora longula, and later with Meloidogyne enterolobii; the leaves were harvested at two maturation times of the plant and placed in an oven. Next, a leaf extract was prepared using ethanol as a solvent. The extract was tested in multidrug-resistant strains of K. pneumoniae carbapenemase from operative wounds using disc diffusion methodology. The plant-AMF-phytonematode interaction positively potentialize the inhibitory action of guava leaf ethanolic extract on multidrug-resistant bacterial strains.

10 February 2023 in Applied Microbiology
Verified
Journal Article
Open access
PDF file
Maíra Cristina MarcolinoMaíra Cristina Marcolino
Maíra Cristina Marcolino
MGMilena Lima Guimarães
Milena Lima Guimarães
Jorge Alexandre Alencar FotiusJorge Alexandre Alencar Fotius
Jorge Alexandre Alencar Fotius
LCLeda Maria Saragiotto Colpini
Leda Maria Saragiotto Colpini
Mateus Matiuzzi da CostaMateus Matiuzzi da Costa
Mateus Matiuzzi da Costa
Helinando De OliveiraHelinando De Oliveira
Helinando De Oliveira
The development of alternative (and free-of-antibiotics) antibacterial and antibiofilm agents is an important strategy to circumvent the resistance of bacteria to antibiotics. Herein, we explore the production of mixed oxides by incorporating silver nanoparticles in titanium dioxide as a silver concentration-dependent antibacterial agent that is further incorporated in Tilapia fish skin (a promising prototype of xenograft), integrating the antibacterial activity of mixed oxide into the intrinsic properties of Tilapia skin. The antibiofilm activity of samples prepared with high concentrations of silver (10 wt% of precursor AgNO3) has been considered a good antibiofilm response. The influence of silver content is also observed with respect to the minimum bactericidal concentration, which is reduced to 3.13 mg/mL with a characteristic kill time in the order of 30 min that is associated with antibiofilm activity in biofilm-forming strains of Staphylococcus aureus. These results indicate that modified Tilapia fish skin acquires antibacterial behavior and can be explored for xenografts with prospective applications in the light-dependent actuation of TiO2-based compounds.

1 January 2020
Verified
Book Chapter
Closed access
Maíra Cristina MarcolinoMaíra Cristina Marcolino
Maíra Cristina Marcolino
MSMárcia Marília de Souza Silva
Márcia Marília de Souza Silva
TAThainara Kauanne Pacheco Almeida
Thainara Kauanne Pacheco Almeida
JJJoão Cleme Ananias de Sousa Junior
João Cleme Ananias de Sousa Junior
VRVictoria Galdino Ramos
Victoria Galdino Ramos
RLRegina Lúcia Félix de Aguiar Lima
Regina Lúcia Félix de Aguiar Lima